Structural analysis of the novel influenza A (H7N9) viral Neuraminidase interactions with current approved neuraminidase inhibitors Oseltamivir, Zanamivir, and Peramivir in the presence of mutation R289K
Main Authors: | Tran-To Su, Chinh, Ouyang, Xuchang, Zheng, Jie, Kwoh, Chee-Keong |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853198/ |
Similar Items
-
Clinical Effectiveness of Peramivir in Comparison with Other Neuraminidase Inhibitors in Pediatric Influenza Patients
by: Hikita, Toshiyuki, et al.
Published: (2012) -
Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections
by: Alame, Malak M., et al.
Published: (2016) -
Influenza neuraminidase
by: Air, Gillian M.
Published: (2011) -
Dry extract BNO 1011 inhibits human influenza a replication and neuraminidase activity in oseltamivir-resistant and -sensitive viral strains
by: Seifert, Stephanie, et al.
Published: (2013) -
Comparison of efficacy and safety of oseltamivir and zanamivir in pandemic influenza treatment
by: Tuna, Nazan, et al.
Published: (2012)